loading
전일 마감가:
$6.52
열려 있는:
$6.57
하루 거래량:
362.29K
Relative Volume:
0.53
시가총액:
$372.15M
수익:
$2.81M
순이익/손실:
$-97.34M
주가수익비율:
-4.3544
EPS:
-1.58
순현금흐름:
$-91.47M
1주 성능:
+0.88%
1개월 성능:
-2.41%
6개월 성능:
+78.70%
1년 성능:
-21.73%
1일 변동 폭
Value
$6.45
$6.915
1주일 범위
Value
$6.39
$7.09
52주 변동 폭
Value
$2.315
$9.90

Fulcrum Therapeutics Inc Stock (FULC) Company Profile

Name
명칭
Fulcrum Therapeutics Inc
Name
전화
617-651-8851
Name
주소
26 LANDSDOWNE STREET, CAMBRIDGE, MA
Name
직원
45
Name
트위터
@fulcrumtx
Name
다음 수익 날짜
2024-11-05
Name
최신 SEC 제출 서류
Name
FULC's Discussions on Twitter

FULC을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
Biotechnology icon
FULC
Fulcrum Therapeutics Inc
6.88 359.17M 2.81M -97.34M -91.47M -1.58
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
395.12 99.96B 11.39B 3.64B 3.50B 13.99
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
589.48 60.83B 14.21B 4.46B 3.56B 39.68
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
454.38 59.89B 2.46B -319.09M -52.09M -2.47
Biotechnology icon
ARGX
Argen X Se Adr
660.00 40.47B 3.06B 1.28B 447.35M 21.30
Biotechnology icon
ONC
Beone Medicines Ltd Adr
313.67 37.96B 3.81B -644.79M -669.77M -6.24

Fulcrum Therapeutics Inc Stock (FULC) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2025-07-29 업그레이드 H.C. Wainwright Neutral → Buy
2025-05-23 업그레이드 Leerink Partners Market Perform → Outperform
2025-05-15 업그레이드 Cantor Fitzgerald Neutral → Overweight
2024-09-13 다운그레이드 H.C. Wainwright Buy → Neutral
2024-09-12 다운그레이드 BofA Securities Neutral → Underperform
2024-09-12 다운그레이드 Cantor Fitzgerald Overweight → Neutral
2024-09-12 다운그레이드 Leerink Partners Outperform → Market Perform
2024-09-12 다운그레이드 RBC Capital Mkts Outperform → Sector Perform
2024-09-12 다운그레이드 Stifel Buy → Hold
2024-09-09 업그레이드 BofA Securities Underperform → Neutral
2024-05-20 개시 Cantor Fitzgerald Overweight
2024-03-13 개시 RBC Capital Mkts Outperform
2023-09-25 개시 Goldman Neutral
2023-08-23 업그레이드 H.C. Wainwright Neutral → Buy
2023-08-22 업그레이드 Stifel Hold → Buy
2023-05-04 다운그레이드 Goldman Buy → Neutral
2023-03-10 다운그레이드 Credit Suisse Outperform → Neutral
2023-03-10 다운그레이드 H.C. Wainwright Buy → Neutral
2023-03-09 다운그레이드 Stifel Buy → Hold
2023-02-28 다운그레이드 Morgan Stanley Overweight → Equal-Weight
2023-02-24 다운그레이드 BofA Securities Neutral → Underperform
2022-11-15 개시 Goldman Buy
2022-03-08 개시 Oppenheimer Outperform
2022-03-03 업그레이드 BofA Securities Underperform → Neutral
2021-08-11 업그레이드 Morgan Stanley Equal-Weight → Overweight
2021-04-26 재개 Credit Suisse Outperform
2021-03-22 개시 Credit Suisse Outperform
2021-03-02 개시 Stifel Buy
2020-10-16 개시 Piper Sandler Overweight
2020-08-12 다운그레이드 BofA Securities Neutral → Underperform
2020-08-12 재확인 H.C. Wainwright Buy
2020-08-12 다운그레이드 Morgan Stanley Overweight → Equal-Weight
2020-06-19 다운그레이드 BofA/Merrill Buy → Neutral
2020-06-17 개시 BTIG Research Buy
2019-10-03 개시 H.C. Wainwright Buy
2019-08-12 개시 BofA/Merrill Buy
모두보기

Fulcrum Therapeutics Inc 주식(FULC)의 최신 뉴스

pulisher
Aug 20, 2025

Full technical analysis of Fulcrum Therapeutics Inc. stockJuly 2025 Reactions & Technical Entry and Exit Alerts - Newser

Aug 20, 2025
pulisher
Aug 20, 2025

Will Fulcrum Therapeutics Inc. benefit from macro trendsWeekly Trading Summary & Verified Momentum Stock Watchlist - Newser

Aug 20, 2025
pulisher
Aug 20, 2025

Will earnings trigger a reversal in Fulcrum Therapeutics Inc.2025 Sector Review & Proven Capital Preservation Methods - Newser

Aug 20, 2025
pulisher
Aug 20, 2025

Analyzing Fulcrum Therapeutics Inc. with risk reward ratio chartsJuly 2025 Earnings & Reliable Momentum Entry Alerts - Newser

Aug 20, 2025
pulisher
Aug 20, 2025

Building trade automation scripts for Fulcrum Therapeutics Inc.Gold Moves & AI Enhanced Trading Alerts - Newser

Aug 20, 2025
pulisher
Aug 20, 2025

Analysts Apply Wyckoff Model to Fulcrum Therapeutics Inc. Stock2025 Investor Takeaways & Reliable Breakout Stock Forecasts - kangso.co.kr

Aug 20, 2025
pulisher
Aug 20, 2025

How high can Fulcrum Therapeutics Inc. stock goQuarterly Profit Summary & Daily Volume Surge Signals - Newser

Aug 20, 2025
pulisher
Aug 19, 2025

Risk vs reward if holding onto Fulcrum Therapeutics Inc.2025 Volatility Report & Fast Exit and Entry Trade Guides - Newser

Aug 19, 2025
pulisher
Aug 19, 2025

What indicators show strength in Fulcrum Therapeutics Inc.Weekly Profit Recap & Safe Entry Trade Reports - Newser

Aug 19, 2025
pulisher
Aug 19, 2025

Real time pattern detection on Fulcrum Therapeutics Inc. stockJuly 2025 Catalysts & Reliable Price Action Trade Plans - Newser

Aug 19, 2025
pulisher
Aug 19, 2025

Published on: 2025-08-19 17:11:19 - Newser

Aug 19, 2025
pulisher
Aug 19, 2025

Is Fulcrum Therapeutics Inc. meeting your algorithmic filter criteriaWeekly Profit Analysis & Reliable Entry Point Trade Alerts - Newser

Aug 19, 2025
pulisher
Aug 19, 2025

Applying big data sentiment scoring on Fulcrum Therapeutics Inc.Trade Risk Report & Free Expert Approved Momentum Trade Ideas - Newser

Aug 19, 2025
pulisher
Aug 19, 2025

Will earnings trigger a reversal in Fulcrum Therapeutics IncSell Signal & Daily Volume Surge Trade Alerts - Newser

Aug 19, 2025
pulisher
Aug 19, 2025

Will Fulcrum Therapeutics Inc. rebound enough to break evenPortfolio Growth Summary & Weekly Top Gainers Alerts - Newser

Aug 19, 2025
pulisher
Aug 19, 2025

When is the best time to exit Fulcrum Therapeutics Inc.July 2025 Sector Moves & Stepwise Entry and Exit Trade Signals - Newser

Aug 19, 2025
pulisher
Aug 19, 2025

Measuring Fulcrum Therapeutics Inc.’s beta against major indicesPortfolio Gains Report & Verified Stock Trade Ideas - Newser

Aug 19, 2025
pulisher
Aug 17, 2025

Using Ichimoku Cloud for Fulcrum Therapeutics Inc. technicalsPortfolio Value Summary & Low Risk Entry Point Tips - Newser

Aug 17, 2025
pulisher
Aug 17, 2025

Fulcrum defended at H.C. Wainwright after data for sickle cell disease drug - MSN

Aug 17, 2025
pulisher
Aug 16, 2025

Comparing Fulcrum Therapeutics Inc. in custom built stock radarsMarket Movement Recap & Long Hold Capital Preservation Plans - Newser

Aug 16, 2025
pulisher
Aug 16, 2025

Is Fulcrum Therapeutics Inc. a Top Dividend Stock to Watch in 2025Stock Surge & Free High Accuracy Swing Entry Alerts - Newser

Aug 16, 2025
pulisher
Aug 16, 2025

Chart overlay techniques for tracking Fulcrum Therapeutics Inc.2025 Big Picture & Free Safe Capital Growth Stock Tips - Newser

Aug 16, 2025
pulisher
Aug 15, 2025

Forecasting Fulcrum Therapeutics Inc. price range with options dataTreasury Yields & Community Verified Swing Trade Signals - Newser

Aug 15, 2025
pulisher
Aug 15, 2025

Quant Models Detect Momentum Reversal in Fulcrum Therapeutics Inc.2025 Trading Volume Trends & Proven Capital Preservation Methods - sundaytimes.kr

Aug 15, 2025
pulisher
Aug 15, 2025

What recovery options are there for Fulcrum Therapeutics Inc.Market Growth Summary & Real-Time Volume Trigger Notifications - Newser

Aug 15, 2025
pulisher
Aug 14, 2025

Will Fulcrum Therapeutics Inc. Bounce From 52 Week LowTrade Signal Summary & Free Low Drawdown Momentum Trade Ideas - classian.co.kr

Aug 14, 2025
pulisher
Aug 14, 2025

XTX Topco Ltd Takes Position in Fulcrum Therapeutics, Inc. (NASDAQ:FULC) - Defense World

Aug 14, 2025
pulisher
Aug 14, 2025

What makes Fulcrum Therapeutics Inc. stock price move sharplyJuly 2025 Market Mood & Risk Managed Investment Strategies - Newser

Aug 14, 2025
pulisher
Aug 13, 2025

Technical signs of recovery in Fulcrum Therapeutics Inc.2025 Trading Volume Trends & Real-Time Market Trend Scan - Newser

Aug 13, 2025
pulisher
Aug 12, 2025

Key External Factors That Drive Fulcrum Therapeutics Inc. Stock Price MovementsFree Entry Alert Based on Volume Spikes - Newser

Aug 12, 2025
pulisher
Aug 12, 2025

Does Fulcrum Therapeutics Inc. qualify in momentum factor screeningBollinger Band Squeeze and Expansion Analysis - Newser

Aug 12, 2025

Fulcrum Therapeutics Inc (FULC) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading
$24.65
price up icon 0.94%
$85.04
price down icon 1.72%
$26.20
price up icon 0.73%
$110.88
price up icon 0.10%
$131.88
price down icon 0.54%
biotechnology ONC
$313.67
price down icon 0.10%
자본화:     |  볼륨(24시간):